Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00598117 · ClinicalTrials.gov registry record
Quality Of Life Outcomes Following Treatment for Esophageal Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 409
- Enrollment target
NCT00598117: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00598117 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 409 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00598117 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 409 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate how treatment for esophageal cancer affects your quality of life. The findings of this study may help us understand how this disease and its treatment affect your lifestyle, diet, exercise, support system and overall quality of life. We hope this study will provide important information that can be used to develop programs to improve the quality of life of patients with esophageal cancer.
Interventions
- BEHAVIORAL Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 409 participants |
| Start Date | 2003-08 |
| Est. Completion | 2013-06 |
What the finished NCT00598117 record still lists
NCT00598117 is an observational study that tracks outcomes without assigning an intervention. The registered 409 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires is the first listed.
NCT00598117 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00598117 about?
NCT00598117 is a clinical study titled "Quality Of Life Outcomes Following Treatment for Esophageal Cancer". The goal of this study is to evaluate how treatment for esophageal cancer affects your quality of life. The findings of this study may help us understand how this disease and its treatment affect your lifestyle, diet, exercise, support system and overall quality of life. We hope this study will prov...
What is the current status of trial NCT00598117?
This trial is currently completed. The enrollment target is 409 participants. The study started on 2003-08. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00598117?
The interventions under investigation include: Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00598117?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06717334 · 409 participants
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia